These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16480245)

  • 41. Sexual disinhibition in schizophrenia possibly induced by risperidone and quetiapine.
    Lam MH; Fong SY; Wing YK
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):333. PubMed ID: 17472606
    [No Abstract]   [Full Text] [Related]  

  • 42. Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.
    Takahashi M; Ohishi S; Katsumi C; Moriya T; Miyaoka H
    Pharmacopsychiatry; 2005 Jul; 38(4):183-4. PubMed ID: 16025424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract]   [Full Text] [Related]  

  • 44. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New onset diabetes with ketoacidosis attributed to quetiapine.
    Marlowe KF; Howard D; Chung A
    South Med J; 2007 Aug; 100(8):829-31. PubMed ID: 17713311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents.
    Turkel SB; Jacobson J; Munzig E; Tavaré CJ
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):126-30. PubMed ID: 22364403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone- and quetiapine-induced cholestasis.
    Wright TM; Vandenberg AM
    Ann Pharmacother; 2007 Sep; 41(9):1518-23. PubMed ID: 17666578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities.
    Ruedrich SL; Swales TP; Rossvanes C; Diana L; Arkadiev V; Lim K
    J Intellect Disabil Res; 2008 Feb; 52(Pt 2):132-40. PubMed ID: 18197952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.
    Bozikas VP; Deseri C; Pitsavas S; Karavatos A
    Can J Psychiatry; 2003 Jul; 48(6):426-7. PubMed ID: 12894620
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate.
    Lin YH; Liu CY; Hsiao MC
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):613-5. PubMed ID: 16194268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 52. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
    Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
    Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subjective well-being in schizophrenia: a randomised controlled open-label 12-month non-inferiority study comparing quetiapine XR with risperidone (RECOVER).
    Naber D; Peuskens J; Schwarzmann N; Goltz M; Krüger H; Lambert M; Haro JM
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1257-69. PubMed ID: 23953270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Type 2 diabetes mellitus induced by an atypical antipsychotic medication.
    Sneed KB; Gonzalez EC
    J Am Board Fam Pract; 2003; 16(3):251-4. PubMed ID: 12755254
    [No Abstract]   [Full Text] [Related]  

  • 56. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.
    Koller EA; Weber J; Doraiswamy PM; Schneider BS
    J Clin Psychiatry; 2004 Jun; 65(6):857-63. PubMed ID: 15291665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diabetes and atypical neuroleptics.
    Geller WK; MacFadden W
    Am J Psychiatry; 2003 Feb; 160(2):388; author reply 389. PubMed ID: 12562601
    [No Abstract]   [Full Text] [Related]  

  • 58. Quetiapine and long-term weight change: a comprehensive data review of patients with schizophrenia.
    Brecher M; Leong RW; Stening G; Osterling-Koskinen L; Jones AM
    J Clin Psychiatry; 2007 Apr; 68(4):597-603. PubMed ID: 17474816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quetiapine-induced diabetes with metabolic acidosis.
    Meyer JM; Leckband SG; Loh C; Moutier CY
    Int Clin Psychopharmacol; 2004 May; 19(3):169-71. PubMed ID: 15107661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypokalemia from risperidone and quetiapine overdose.
    Malik AR; Wolf PK; Ravasia S
    Can J Psychiatry; 2005 Jan; 50(1):76. PubMed ID: 15754671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.